======= PTMA ======= == Gene Information == * **Official Symbol**: PTMA * **Official Name**: prothymosin alpha * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5757|5757]] * **UniProt**: [[https://www.uniprot.org/uniprot/P06454|P06454]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PTMA&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PTMA|Open PubMed]] * **OMIM**: [[https://omim.org/entry/188390|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Prothymosin alpha may mediate immune function by conferring resistance to certain opportunistic infections. |Prothymosin| |activating transcription factor binding| |histone exchange| |ATP-dependent chromatin remodeling| |histone binding| |nucleosome organization| |chromatin remodeling| |protein-DNA complex subunit organization| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |chromatin organization| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |negative regulation of cell death| |chromosome organization| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |regulation of apoptotic process| |regulation of programmed cell death| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |regulation of cell death| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |protein-containing complex subunit organization| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-2.46| |[[:results:exp67|BVD-523 15μM R02 exp67]]|-2.07| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-2.05| |[[:results:exp244|SB743921 0.001μM R05 exp244]]|-1.88| |[[:results:exp27|Pimelic-diphenylamide-106 0.5μM R00 exp27]]|1.7| |[[:results:exp444|THZ531 0.225μM R08 exp444]]|1.7| |[[:results:exp13|Chloramphenicol 20μM R00 exp13]]|1.77| |[[:results:exp274|Citral 50μM R06 exp274]]|1.79| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|1.8| |[[:results:exp183|IU1-C 25μM R04 exp183]]|1.81| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|1.83| |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|1.85| |[[:results:exp330|5-Azacytidine 2μM R07 exp330]]|1.86| |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|1.86| |[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|1.87| |[[:results:exp415|Trichostatin-A 0.06μM R07 exp415]]|1.87| |[[:results:exp241|QNZ 0.01μM R05 exp241]]|1.88| |[[:results:exp534|Trientine 500μM R08 exp534]]|1.96| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|1.97| |[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|1.97| |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|2.05| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|2.07| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|2.11| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|2.14| |[[:results:exp134|MS023 2μM R03 exp134]]|2.25| |[[:results:exp85|UM0129480 7μM R02 exp85]]|2.25| |[[:results:exp447|Amiloride 100μM R08 exp447]]|2.28| |[[:results:exp380|NMS-873 0.07μM R07 exp380]]|2.41| |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|2.62| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|2.82| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|2.98| |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|3.3| |[[:results:exp18|Doxycycline 10μM R00 exp18]]|3.31| |[[:results:exp485|GSK626616 14μM R08 exp485]]|3.41| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|3.98| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|4.14| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|4.17| ^Gene^Correlation^ |[[:human genes:d:ddx3x|DDX3X]]|0.516| |[[:human genes:g:glyr1|GLYR1]]|0.433| |[[:human genes:p:pmaip1|PMAIP1]]|0.43| |[[:human genes:p:prim1|PRIM1]]|0.43| |[[:human genes:i:ikzf2|IKZF2]]|0.419| |[[:human genes:c:ctnnbl1|CTNNBL1]]|0.414| |[[:human genes:c:cnbp|CNBP]]|0.41| |[[:human genes:a:anp32a|ANP32A]]|0.409| Global Fraction of Cell Lines Where Essential: 3/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|1/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|1/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1236 * **Expression level (log2 read counts)**: 11.39 {{:chemogenomics:nalm6 dist.png?nolink |}}